Corvus Pharmaceuticals, Inc. - CRVS
About Gravity Analytica
Recent News
- 05.08.2025 - Corvus Pharmaceuticals First Quarter 2025 Earnings Conference Call
- 05.08.2025 - Corvus Pharmaceuticals First Quarter 2025 Earnings Conference Call
- 04.23.2025 - Corvus Pharmaceuticals to Present New Interim Data from Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis on May 8, 2025
- 04.23.2025 - Corvus Pharmaceuticals to Present New Interim Data from Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis on May 8, 2025
- 04.23.2025 - Corvus Pharmaceuticals to Present New Interim Data from Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis on May 8, 2025
- 04.09.2025 - Corvus Pharmaceuticals Appoints Richard A. van den Broek to Board of Directors
- 04.09.2025 - Corvus Pharmaceuticals Appoints Richard A. van den Broek to Board of Directors
- 04.09.2025 - Corvus Pharmaceuticals Appoints Richard A. van den Broek to Board of Directors
- 03.27.2025 - H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference
- 03.27.2025 - H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference